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Abstract. In the present study, a monoclonal anti- 
body (McAb), ALD19, generated against myosin of 
slow tonic muscle, was shown to react with the heavy 
chain of ventricular myosin in the adult chicken 
heart. With this antibody, it was possible to detect a 
ventricular-specific myosin during myocardial differ- 
entiation and to show that the epitope recognized by 
ALD19 was present from the earliest stages of ventric- 
ular differentiation and maintained throughout devel- 
opment only in the ventricle. A second McAb, specific 
for atrial myosin heavy chain (MHC) (Gonzalez-San- 
chez, A., and D. Bader,  1984, Dev. Biol.,  103:151- 
158), was used as a control to detect an atrial-specific 
myosin in the caudal portion of the developing heart 
at Hamburger-Hamilton stage 15. It was found that 
the appearance of ventricular MHC predated the 
expression of atrial MHC by ~ 1 d in ovo and that 
specific MHCs were always differentially distributed. 
While a common primordial MHC may be present in 
the early heart, this study showed the tissue-specific 
expression of a ventricular MHC during the initial 
stages of heart development and its differential accu- 
mulation throughout development. 
S 
EVERAL recent studies have shown the heterogeneity of 
myosin heavy chain (MHC)  ~  expression in the hearts of 
adult avians and mammals (4, 5,  1  l, 13, 14, 16, 20, 21, 
26-28,  30,  34). In  addition,  biochemical  (4), immuno- 
chemical (4,  5), and molecular cloning (21, 30) techniques 
have detected two different MHCs in mammalian ventricles, 
which exist as either homo- or heterodimers of myosin (24), 
and whose expression  is responsive to the hormonal state of 
the animal (4,  10,  16,  30). In mammals, one of the major 
cardiac MHCs (beta-form)  is identical to the slow  skeletal 
isoform (22), and the major atrial MHC is identical to the 
beta-form of the ventricles  (18). The avian heart has been 
shown to  have distinct atrial,  ventricular, and conductive 
system MHCs (6, 1  l, 22, 27, 32). In contrast, the ventricular 
MHC of the avian heart is immunochemically distinct from 
the slow tonic isoform (32), and the atrial MHC is a distinct 
isoform in that it has no ventricular counterpart (6,  11, 12). 
Cardiac  myogenesis is  also  typified by  the  diversity of 
myosin  components.  Electrophoretic  analysis  of  native 
myosin has shown that the expression of at least two different 
ventricular MHCs is developmentally regulated within the 
ventricles  of several different species (5,  20), whereas  other 
species,  including  some  avians,  exhibit  a  single  myosin 
throughout development (23). The accumulation of specific 
ventricular MHC  isoforms appears  to  be  transcriptionally 
controlled (21, 30). 
Abbreviations used in this paper." McAb. monoclonal antibody~ MHC, myosin 
heavy chain; RIA, radioimmune assay: GAM, goat anti-mouse immunoglob- 
ulin. 
Although previous studies have documented the expression 
of myosin components during the later stages of embryonic 
life  and  in  the  adult organism,  little  is  known about  the 
expression of MHC during the initial stages of cardiac myo- 
genesis. Ebert and co-workers (8, 9) used anti-sera generated 
against adult heart myosin to demonstrate myosin early in 
the formation of  the heart, but could not differentiate between 
different isoforms of myosin that might be expressed due to 
the polyclonal nature of  their antibody preparation. The study 
of myosin polymorphism in  the  early embryonic heart  is 
complicated by the lack of specific reagents to study MHC 
expression and the small amount of tissue available for study. 
We have used monoclonal antibody (McAb) technology to 
examine the expression of MHCs during the initial phases of 
avian cardiac myogenesis  (11, 12). In one study (11), an atrial- 
specific  MHC was  detected at  or  near the  onset of atrial 
myogenesis, and the expression of this MHC was confined to 
atrial-forming tissues. Sweeney et al. (32) have demonstrated 
the  antigenic relatedness  of MHCs in the  early heart and 
hypothesized that the first MHC produced in all differentiat- 
ing striated muscle may be related to the cardiac ventricular 
myosin. In this study, an McAb reactive with an MHC of the 
adult chicken ventricle was used to determine the distribution 
of MHCs  within  the  developing  heart.  The  present  data 
demonstrate the tissue-specific distribution and accumulation 
of a  ventricular-specific  MHC within the ventricles  of the 
differentiating  heart from the initial stages of cardiac myogen- 
esis. 
© The Rockefeller  University Press, 0021-9525/86/04/1480/05 $1.00 
The Journal of Cell Biology, Volume 102, April  1986 1480-1484  1480 Materials and Methods 
Protein Preparation 
Myosins were prepared from dissected atria and ventricles by homogenization 
in  ice-cold  150  mM  NaCI,  l0  mM  NaH2PO4, 10  mM  Na2HPO4 (pH 7.2) 
including  1 mM  EGTA,  0.1  mM  phenylmethylsulfonyl  fluoride,  and 0.1% 
Triton  X-100 (10:1; vol/wt)  with an Omnimixer (Sorvall, two 10-s bursts at 
top speed). The homogenate  was spun at lfl,000 rpm in an SS34 rotor for 10 
min and the resulting  pellet was resuspended  in  the aforementioned  buffer 
(10:1; vol/wt).  The cycle of centrifugation  and extraction  was repeated  until 
the resulting supernatant  was clear (usually four or five cycles). The final pellet 
was resuspended  in the homogenization  buffer without Triton X-100, centri- 
fuged, and the pellet extracted  in cold 0.3  M KCI, 0.1  M  KH2PO4, 50 mM 
K~HPO4 (3:1; vol/wt)  for  10 min.  The extraction  was terminated  by centrif- 
ugation  (10,000 rpm, SS34 rotor,  10 min),  and the  supernatant  was diluted 
10x  with cold distilled H20.  The precipitant  was collected by centrifugation 
(10,000 rpm, SS34 rotor,  10 min). The pellet was made 0.5  M NaCI, 5 mM 
MgCI2, 5 mM ATP and spun at 45,000 rpm for 2 h in a Ti70.1 rotor (Beckman 
Instruments, Inc.,  Palo  Alto,  CA). Crude  myosin  was  collected  from  the 
resulting supernatant  by precipitation (i < 0.05) and subsequent centrifugation 
( 10,000 rpm, SS34 rotor,  10 min). Myosin was purified to homogeneity by ion 
exchange (DEAE) chromatography  using a  linear  KC1 gradient  (0.0-0.5  M) 
(25). Purified  myosin  was stored  at  5-10  mg/ml in 0.5  M  NaC1 and  50% 
glycerol at -20"C. To assay for the appearance  of myosins in the early heart 
(stages 9-21  [15]), specific regions  of the  heart  were  micro-dissected  and 
extracted  in  10 #1 of 0.5 M NaCI,  10 mM Na2HPO4, 10 mM NaH2PO4 (pH 
7.6) with 0.1% Triton X- 100 for 10-16 h. The tissue/extract in buffer was then 
spun in a microfuge for 10 min, and the supernatant  was collected and dried 
for solid-phase, indirect radioimmunoassay  (RIA). 
lmmunoglobulins from  monoclonal  cell lines were purified  from  condi- 
tioned cell culture media by affinity chromatography on columns of Sepharose 
4B conjugated  with  specific myosins  or goat  anti-mouse immunoglobulins 
(GAMs) (Cappel Laboratories, Cochranville, PA). Antibodies were eluted with 
0.2 M glycine (pH 2.2) into equal volumes of  0.2 M Tris (pH 8.1), and protein- 
containing fractions were immediately dialyzed against 150 mM NaCI, 10 mM 
NaH~PO4, 10 mM Na2HPO4 (pH 7.2), concentrated  to 5-10 mg/ml by ultra- 
filtration and stored at -20"C until use. 
Immunochemical Analysis and McAbs 
RIAs, immunoradiography,  and immunofluoresccnce  microscopy were done 
using published methods (1, 11, 19). The McAbs used here were produced from 
several different  cell fusions.  Myosin  from anterior  latissimus dorsi  (McAb 
ALDI9) or pectoralis (McAbs MF20 and BI) muscles were used as antigens. 
These cell lines have been recloned several times without any change in antibody 
specificity. Details of this production  have been published (1,  11, 29). There 
specificities are discussed below (Results). 
Radiolabeling of  Myosin and 
Affinity Chromatography 
Myosin from adult  or 5<1 embryonic  ventricles recovered after ion exchange 
chromatography  was radiolabeled  with  ~2~i (New  England  Nuclear,  Boston, 
MA)  by  the  Enzymobead  reagent  (BioRad  Laboratories,  Richmond,  CA). 
DEAE-purified myosin was precipitated  in  10 vol of cold distilled H20 after 
the pH was adjusted to 6.8. The precipitated myosin was collected by centrif- 
ugation and redissolved in 0.3 M NaCI, 10 mM Na2HPO4, 10 mM NaH2PO4, 
pH 7.4 at a concentration  of 4 mg/ml. 100 ~g of this preparation was iodinated 
using the manufacturer's  directions. 
Radiolabeled  myosin was separated from free iodine on a Sephadex G-25 
column (0.5 x  20 cm) equilibrated in 0.3 M NaCI, 10 mM NaH2PO4, 10 mM 
Na2HPO4 (pH 7.2). Fractions that contained  myosin were collected and spun 
in an airfuge (Beckman Instruments, Inc.) for 10 min at 30 psi. Specific  activities 
of supernatants  were determined  and made 0.1% in bovine  serum albumin 
from a  10  mg/ml stock  in  0.3  M  NaCI.  Samples  were  used  with  7 d  of 
iodination. 
GAM (Cappel Laboratories)  was covalently linked to Sepharose 4B using 
the manufacturer's  instructions  (Pharmacia  Fine Chemicals, Piscataway, N  J). 
Hybridoma supernatants  that contained  McAbs were passed over GAM beads 
until  the beads were saturated  as determined  from RIA for the presence of 
unbound McAb in the column effluent. Radiolabeled myosin was reacted with 
these antibody/bead  complexes batch-style in 1.5-ml Eppendorftubes for 2-24 
h at 4"C. After reaction the beads were washed with the buffer that contained 
0.3 M NaCI, 10 mM Na2HPO4, 10 mM NaH2PO~, pH 7.4 until no cpm were 
detected  in the wash buffer. Bound cpm were eluted  in  1% sodium dodecyl 
?  • 
sulfate,  10 mM Tris,  pH 6.8,  1 mM  EDTA. Counts were adjusted  to  104-10  ~ 
cpm/#l and l  mg/ml with the appropriate  myosin. 
Bound radioactive  myosin was analyzed by peptide  mapping using Staphy- 
lococcus aureus protease (Miles-Yeda, Rehovot, Israel) and alpha-chymotrypsin 
(Worthington  Biochemical Corp.,  Freehold,  N J) according to Bandman et al. 
(2). Protein/enzyme ratios were adjusted to permit total digestion of the MHC. 
Digests were applied  to 10% polyacrylamide gels, and after electrophoresis,  the 
gels were dried and used to expose x-ray film  (Kodak X-OMAT AR-5). 
Results 
Specificity of  McAb ALD19 for Ventricular  MHC 
McAbs generated from several cell fusions were screened for 
their reactivities with cardiac myosin.  One McAb,  ALD19, 
which  was generated  against  ALD  myosin,  was  studied  in 
greater detail. Immunoblots with ALD19 showed strong reac- 
tivity  with  ventricular  MHC,  whereas  very  faint  reactivity 
with atrial MHC was detected in some preparations with long 
film exposures (Fig.  1). To determine the cellular distribution 
of heavy chains recognized by ALD19,  tissue sections were 
treated for immunofluorescence microscopy. As seen in Fig. 
2, all ventricular myocytes were stained by ALD19,  whereas 
atrial cells were negative for this antibody. Occasional ALD 19, 
immunofluorescence positive cells were seen in the atria near 
their junction with the ventricles. McAb B 1, specific for atrial 
MHC (11),  was used as a  control in  the present study and 
recognized  MHCs  present  in  atrial  myocardium,  but  was 
negative for all cells of the ventricle (Fig. 2). Endothelial cells, 
smooth muscle, and all elements of the connective tissue were 
completely negative for all anti-MHC antibodies. The reac- 
tivities of these  antibodies have not been extensively tested 
with  skeletal  muscles  other  than  the  ALD  and  pectoralis 
muscles. These results demonstrate the specificity of ALD 19 
for ventricular myocytes in the heart. 
Reaction of  ALD19 with Ventricular  Myosin Isolated 
from Embryonic Hearts 
To examine possible antigenic similarities or differences be- 
tween adult and  embryonic ventricular MHC,  ALD19  was 
reacted  with  preparations  of  myosin  at  selected  stages  of 
development. Binding of this McAb was confined primarily 
to the ventricles in early and late embryonic life, while slight 
reactivity of ALD 19 with high concentrations of atrial myosin 
was detected  in  some  preparations.  This  reactivity  may be 
due to contamination of the atrial preparation with ventric- 
ular myosin or minor cross-reactivity of ALDI9  with atrial 
myosin.  BI,  an  antibody that  recognizes only atrial  MHC, 
showed  no  binding  to  ventricular  myosin  over all  protein 
concentrations  tested.  When  tissue  sections  of  embryonic 
Figure 1. Coommassie Brilliant 
Blue-stained  gel  (A)  shows 
myosin prepared from atria (a) 
and  ventricles  (v)  of  adult 
chickens.  Asterisk  denotes 
heavy  chain.  Accompanying 
blot  (B)  shows  specificity  of 
ALDI9  for  the  ventricular 
MHC. 
Zhang et al.  Ventricular MHC in the Developing Heart  1481 hearts were reacted with anti-MHC antibodies, the pattern of 
immunoreactivity was the same as that detected in the adult 
(Fig. 2). Within the limits of the light microscope, all ventric- 
ular muscle cells were stained with ALDI9 at all stages tested, 
while a limited number of atrial myocytes at atrioventricular 
junction were positive with this antibody. 
Radiolabeled embryonic (5 d) and adult ventricular myo- 
sins were reacted with ALDI9 and peptide mapped to exam- 
ine the structure of these proteins. Under conditions in which 
the heavy chain was completely digested by V8 protease or 
chymotrypsin, the radioactive bands in embryonic and adult 
preparations appeared homologous in molecular weight (Fig. 
3, A  and B).  Differences in the labeling intensity of several 
bands between the two preparations could be seen in the V8 
protease  digests  (Fig.  3A),  but  these  variations  were  most 
probably due  to differences in  the  amount  of radioactivity 
loaded as all bands could be identified in both embryonic and 
adult myosins. In addition, variant bands, which were always 
of  low intensity, were readily visible upon longer film exposure 
and,  invariably,  matched the accompanying digest.  Varying 
enzyme concentration or time of digestion did not produce 
any diversity in bands of the digestion patterns between the 
two samples. 
Appearance of the Epitope Recognized by ALD19 
during the Initial Stages of Heart Formation 
RIA  of isolated  regions  of the  forming  heart  were  run  in 
parallel  with  analyses previously published  (1 l) to establish 
the earliest stage at which ALDI9 reacted with heart myosin. 
(The reaction of atrial-specific antibody B l  is provided here 
as a reference.) The first significant reactivity of ALD 19 with 
the tubular heart was observed in the presumptive ventricle 
(region  3)  at  stage  l0  (Fig.  4).  Limited  reactivity  was  also 
observed in atrial forming tissues, but this reactivity was not 
positively confirmed using immunofluorescence microscopy 
(data not shown). Reactivity of ALD  19 increased rapidly and 
was confined to ventricular tissues (Fig. 4). Binding of B 1 was 
observed  ~l-l.5  d  later  in  the  caudal-most  regions  of the 
Figure  2.  Immunofluorescence 
microscopy with ALDI9 and BI. 
Serial  sections  of adult  and  3-d 
embryonic  hearts  reacted  with 
these antibodies show specificity of 
ALDI9 and B1  for the ventricle 
and  atrium,  respectively. Atrium 
(A, a);  ventricle  (V,  v).  Bar, 100 
#m. 
Figure 3. (a) Peptide maps of 
ALD19 affinity bound 5-d em- 
bryonic  and  adult  ventricular 
myosin produced  by digestion 
with S. aureus V8 protease,  l0 
~g  of  carrier  myosin  and 
50,000 cpm of affinity bound 
myosin were digested with 0. l 
mg/ml of V8 protease.  Adult 
(A)  and  5-d  embryonic  (B) 
preparations  are noted.  Aster- 
isks denote bands that differ in 
intensity between the two prep- 
arations.  (b)  Peptide  maps  of 
ALD19 affinity bound 5-d em- 
bryonic  and  adult  ventricular 
myosin  digested with  chymo- 
trypsin.  All  conditions  were 
similar except myosin was di- 
gested by chymotrypsin. 
developing heart.  Thereafter, B I  only bound to atrial tissues 
throughout development (Figs.  2 and 4). 
Discussion 
In the present study, a McAb (ALD19) generated against the 
MHC of a slow tonic muscle is shown to react with the MHC 
of ventricular myocardium. At no time does this McAb react 
with myosin from the embryonic or adult atria.  In addition, 
it  is possible to detect the tissue-specific distribution  of the 
ventricular  MHC  recognized  by  ALD19  from  the  earliest 
stages of cardiac myogenesis. Thus, while the expression of a 
common "primordial" MHC throughout the myocardium of 
the developing heart has been  noted (32), the present  study 
demonstrates the tissue-specific appearance and accumulation 
of a ventricular MHC during the earliest stages of ventricular 
cardiac myogenesis. 
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Figure 4.  RIA analysis of early embryonic hearts with ALDI9 (O) 
and B l (0). Tissues were isolated and prepared for RIA as previously 
reported ( 11 ). Horizontal axis represents regions assayed, whereas the 
vertical axis represents the amount of radioactive GAM bound. Each 
point is the average of at least three individual hearts. 
Previous studies have used a variety of techniques to dem- 
onstrate  the  diversity  of MHCs  present  in  the  atria  and 
ventricles of adult mammals and avians (4, 5,  10-14,  16, 20, 
21, 26, 27, 30). In addition, differential expression of myosin 
(20)  and  MHCs (5,  21,  30)  in  developing hearts has been 
observed in many species, while in chickens it appears that a 
single  myosin  is  expressed  in  both  embryonic  and  adult 
ventricles (23). From peptide mapping experiments presented 
here (Fig. 3), it appears that the myosin reactive with ALD19 
in  the  5-d  embryonic and  adult  ventricle  are  remarkably 
similar, if not identical,  even in  different digestive systems. 
The  minor variations in  peptide  maps between  embryonic 
and adult  preparations were limited to slight differences in 
band intensity in the V8 protease digests and not to unique 
bands in  either preparation.  In addition,  our RIA and im- 
munofluorescence data demonstrate that the epitope recog- 
nized  by ALDI9  is  present  throughout  development.  For 
these reasons, we feel that the myosin recognized by ALD19 
in the chambered embryonic and adult ventricle are the same 
protein. Still,  the present data do not determine whether all 
of the ventricular myosin in the developing heart is reactive 
with this McAb. It is possible that sarcomeric myosins non- 
reactive with ALD19 are constantly or transiently present in 
the ventricular myocardium. This point must be considered 
in light of the studies of Sweeney et al. (32),  which suggest 
that all striated muscle (both skeletal and cardiac) of the early 
avian  embryo transiently  produce  an  antigenically  related 
MHC. Future studies will be necessary to determine the total 
number of MHC isoforms expressed in the developing ven- 
tricle of the chicken. 
An MHC reactive with ALD19 is first detected at stage 10 
in the developing heart. This reactivity is confined primarily 
to  that  portion  of the  heart  tube  destined  to  become the 
ventricle.  Earlier  morphological studies  have demonstrated 
that this region of the heart is the first to exhibit cross-striated 
myofibrils (19),  sporadic contractions (17)  and, in addition, 
is the first region where significant numbers of myocardial 
cells  withdraw from the cell cycle (10).  Thus, it is possible 
that the first sarcomeric, cardiac MHC is a "ventricular-like" 
MHC. Our immunofluorescence data reveal that this MHC, 
recognized by its reactivity with ALDI 9, is confined to the 
ventricle. We consider the limited reactivity of ALD 19 with 
atrial-forming tissues (region 5, stage 10) in RIAs (Fig. 4) due 
to contamination of these preparations with ventricular cells 
in that ALD 19 immunofluorescence-positive cells were never 
detected  in  the  developing  atria.  Sweeney  et  al.  (32,  33) 
describe two McAbs specific for adult ventricular myosin that 
react with the cardiac and myotomal myogenic cells in the 
stage 15 of  the chick embryos. They propose that all myogenic 
cells  of striated  muscles  at  this  stage  contain  a  common 
"primordial" myosin. With  ALDI9, however, a  ventricular 
myosin can be identified in stage 10 embryos which is clearly 
antigenically different from atrial myosin that is first detect- 
able at stage 15 and is reactive with the B I antibody. Thus, 
at  stage  15  there  are  already  two  different  tissue-specific 
myosin isoforms in the developing myocardium differentially 
distributed  in  the  heart.  While these  data demonstrate the 
tissue-specific  distribution  of MHCs  in  the  differentiating 
ventricles and atria, we cannot exclude the co-expression of a 
common "primordial" MHC as previously proposed by Swee- 
ney et al.  (32,  33).  Indeed, coexistence of MHC isoforms in 
developing cardiac muscle has been documented for several 
species (13,  30). It is possible that the earliest stages of avian 
cardiac myogenesis include the synthesis of both nonspecific 
and tissue-specific, sarcomeric MHC. 
Several studies have suggested the heterogeneous nature of 
cardiac myoblasts which give rise to the heart myocardium 
(3, 7, 24).  These investigations noted that cardiac myoblasts 
derived from the cardiogenic plate beat at different rates and, 
from these results,  it was postulated that cardiac myoblasts 
are heterogeneous in nature. Ebert and co-workers (8, 9) have 
demonstrated that these myocytes accumulate myosin early 
in  heart development. From the present data and previous 
reports from this laboratory (11 ), it appears that tissue-specific 
expression of ventricular and atrial MHCs is a feature of early 
cardiogenesis.  Still,  the  cellular and  molecular factors that 
give rise to the apparent heterogeneity of MHC expression 
remain unresolved. 
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